aspirin has been researched along with Lung Diseases, Obstructive in 25 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The value of warfarin in preventing stroke in patients with chronic atrial fibrillation is well established." | 7.70 | Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. ( Almoznino-Sarafian, D; Alon, I; Chachashvily, S; Cohen, N; Gorelik, O; Koopfer, M; Litvinjuk, V; Modai, D; Shteinshnaider, M, 2000) |
| "The value of warfarin in preventing stroke in patients with chronic atrial fibrillation is well established." | 3.70 | Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. ( Almoznino-Sarafian, D; Alon, I; Chachashvily, S; Cohen, N; Gorelik, O; Koopfer, M; Litvinjuk, V; Modai, D; Shteinshnaider, M, 2000) |
| " Further dosage adjustments are made in accordance with a set protocol." | 2.67 | The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. ( Hansson, L; Zanchetti, A, 1994) |
| "Aspirin treatment failed to decrease urinary levels of iPF2alpha-III (102 +/- 8 versus 99." | 1.30 | Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. ( Basili, S; Cordova, C; Fitzgerald, GA; Praticò, D; Vieri, M; Violi, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (68.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbstreit, F | 1 |
| Peters, J | 1 |
| Nenci, GG | 1 |
| Parise, P | 1 |
| Capodicasa, E | 1 |
| Berrettini, M | 1 |
| Mantero, O | 1 |
| Colli, S | 1 |
| Maderna, P | 1 |
| Lo Cicero, S | 1 |
| Bertoli, L | 1 |
| Tremoli, E | 1 |
| Novo, S | 1 |
| Davì, G | 2 |
| Caimi, G | 1 |
| Castello, F | 1 |
| Valdes, L | 1 |
| Marino, S | 1 |
| Romano, A | 1 |
| Fazio, M | 1 |
| La Menza, B | 1 |
| Mazzola, A | 1 |
| Seale, JP | 1 |
| Bonaduce, D | 1 |
| Postiglione, M | 1 |
| Ferrara, N | 1 |
| Petretta, M | 1 |
| De Caprio, L | 1 |
| Rengo, F | 1 |
| Cerqua, R | 1 |
| Trovello, C | 1 |
| Infante, G | 1 |
| Ricciardi, S | 1 |
| Carpinteri, F | 1 |
| Carosi, M | 2 |
| Guerrini, M | 1 |
| Gunella, G | 1 |
| Galleri, C | 1 |
| Lappa, B | 1 |
| Di Caterina, N | 1 |
| Perna, A | 1 |
| Di Fraia, C | 1 |
| Verdoliva, A | 1 |
| Margarita, A | 1 |
| Rubegni, M | 1 |
| De Mauro, G | 1 |
| Zuccali, G | 1 |
| Gherson, G | 1 |
| Parenti, M | 1 |
| Pierson, DJ | 1 |
| Small, P | 1 |
| Frenkiel, S | 1 |
| Black, M | 1 |
| Dahlén, SE | 1 |
| Dahlén, B | 1 |
| Kumlin, M | 1 |
| Björck, T | 1 |
| Ihre, E | 1 |
| Zetterström, O | 1 |
| Hansson, L | 1 |
| Zanchetti, A | 1 |
| Basili, S | 3 |
| Ferroni, P | 1 |
| Pulcinelli, FM | 1 |
| Pettirossi, G | 1 |
| Vieri, M | 3 |
| Violi, F | 3 |
| Alessandri, C | 2 |
| Cordova, C | 3 |
| Gazzaniga, PP | 1 |
| Cipollone, F | 1 |
| Santarone, S | 1 |
| Gazzaniga, P | 1 |
| Praticò, D | 1 |
| Fitzgerald, GA | 1 |
| Hedman, J | 1 |
| Kaprio, J | 1 |
| Poussa, T | 1 |
| Nieminen, MM | 1 |
| Cohen, N | 1 |
| Almoznino-Sarafian, D | 1 |
| Alon, I | 1 |
| Gorelik, O | 1 |
| Koopfer, M | 1 |
| Chachashvily, S | 1 |
| Shteinshnaider, M | 1 |
| Litvinjuk, V | 1 |
| Modai, D | 1 |
| Vigdahl, RL | 1 |
| Ferber, RH | 1 |
| Parrish, SL | 1 |
| Fairshter, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 'The Factors Associated With the Formation of Nasal Polyp'[NCT01278719] | 180 participants (Anticipated) | Observational | 2010-01-31 | Recruiting | |||
| Challenge Test for Acetylsalicylic Acid Hypersensitivity[NCT01681615] | 50 participants (Anticipated) | Interventional | 2012-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for aspirin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Prostaglandins, slow-reacting substances (leukotrienes) and the lung.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Asthma; Bronchi; Epoprostenol; Guinea Pigs; H | 1981 |
Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans.
Topics: Allergens; Aspirin; Asthma; Humans; Leukotriene Antagonists; Leukotrienes; Lung Diseases, Obstructiv | 1994 |
10 trials available for aspirin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Effects of guaiacolic ester of acetylsalicylic acid on spirometric and plethysmographic parameters in subjects with chronic obstructive bronchopneumopathy].
Topics: Aged; Aspirin; Bronchitis; Chronic Disease; Clinical Trials as Topic; Female; Humans; Lung Diseases, | 1981 |
[The use of guacetisal in chronic obstructive bronchopneumopathy. Controlled clinical study].
Topics: Aged; Aspirin; Clinical Trials as Topic; Female; Humans; Lung Diseases, Obstructive; Male; Middle Ag | 1981 |
[Guacetisal in the treatment of acute and chronic bronchopneumopathy].
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Aspirin; Asthma; Bronchitis; Bronchodilator Agents; Bron | 1981 |
[Clinical study of a new drug, guacetisal, in the treatment of acute and chronic bronchopneumopathy].
Topics: Adolescent; Adult; Aged; Aspirin; Bronchitis; Bronchopneumonia; Clinical Trials as Topic; Female; Hu | 1981 |
[Evaluation of the therapeutic effects of broncaspin in chronic bronchopneumopathies].
Topics: Adrenal Cortex Hormones; Aminopyrine; Anti-Bacterial Agents; Aspirin; Bronchial Diseases; Clinical T | 1981 |
[Clinico-functional observations on the use of guacetisal in the treatment of chronic obstructive bronchopneumopathy].
Topics: Adult; Aged; Aspirin; Bronchitis; Clinical Trials as Topic; Cough; Humans; Lung Diseases, Obstructiv | 1981 |
[Clinical study of a preparation with bronchomucotropic activity: guacetisal].
Topics: Aged; Aspirin; Bronchitis; Clinical Trials as Topic; Cough; Female; Humans; Lung Diseases, Obstructi | 1981 |
[Clinical trials of a new preparation in chronic bronchopneumopathies].
Topics: Adult; Aged; Aspirin; Asthma; Bronchitis; Chronic Disease; Clinical Trials as Topic; Cough; Female; | 1981 |
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzym | 1994 |
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructi | 1996 |
13 other studies available for aspirin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Spinal anaesthesia despite combined clopidogrel and aspirin therapy in a patient awaiting lung transplantation: effects of platelet transfusion on clotting tests.
Topics: Anesthesia, Spinal; Aspirin; Blood Coagulation; Clopidogrel; Female; Humans; Lung Diseases, Obstruct | 2005 |
Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Humans; Lung Diseas | 1983 |
Pharmacological control of platelet-vessel wall interactions in patients with chronic obstructive airway disease.
Topics: Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Hematopoiesis; Humans; Lung Diseases, Obstruc | 1984 |
Platelet activity in relation to smoke and exercise in patients with chronic obstructive lung disease: effects of platelet antiaggregating drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Female; Humans; Lung Diseases, Obstructive; | 1984 |
Asthma in the elderly: special challenge.
Topics: Adrenal Cortex Hormones; Aged; Aspirin; Asthma; Diagnosis, Differential; Humans; Lung Diseases, Obst | 1982 |
[Clinical experiences with guacetisal].
Topics: Aspirin; Bronchitis; Humans; Lung Diseases, Obstructive; Respiratory Tract Diseases | 1981 |
Multifactorial etiology of nasal polyps.
Topics: Airway Obstruction; Antigen-Antibody Complex; Aspirin; Complement System Proteins; Humans; Immunoglo | 1981 |
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Topics: Aged; Aspirin; Blood Platelets; Creatinine; Cyclooxygenase Inhibitors; Female; Humans; Lung Diseases | 1997 |
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonic Acids; Aspirin | 1998 |
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma; Drug Hypersensitivity; Female; Finland; Humans; Lung Disea | 1999 |
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma; Drug Hypersensitivity; Female; Finland; Humans; Lung Disea | 1999 |
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma; Drug Hypersensitivity; Female; Finland; Humans; Lung Disea | 1999 |
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma; Drug Hypersensitivity; Female; Finland; Humans; Lung Disea | 1999 |
Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; | 2000 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
Airway hysteresis in normal subjects and individuals with chronic airflow obstruction.
Topics: Adult; Airway Resistance; Ascorbic Acid; Aspirin; Bronchi; Female; Humans; Indomethacin; Lung Compli | 1985 |